Cargando…

Prevalence and predictors of irritable bowel syndrome in patients with morbid obesity: a cross-sectional study

BACKGROUND: Irritable bowel syndrome has been reported as more common in patients with morbid obesity than in the general population. The reason for this association is unknown. The aims of this study were to study the prevalence of irritable bowel syndrome and other functional bowel disorders in pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aasbrenn, Martin, Høgestøl, Ingvild, Eribe, Inger, Kristinsson, Jon, Lydersen, Stian, Mala, Tom, Farup, Per G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5490229/ https://www.ncbi.nlm.nih.gov/pubmed/28680646 http://dx.doi.org/10.1186/s40608-017-0159-z

Ejemplares similares

Irritable bowel syndrome-like symptoms and health related quality of life two years after Roux-en-Y gastric bypass - a prospective cohort study
por: Blom-Høgestøl, Ingvild Kristine, et al.
Publicado: (2019)

A Conservative Weight Loss Intervention Relieves Bowel Symptoms in Morbidly Obese Subjects with Irritable Bowel Syndrome: A Prospective Cohort Study
por: Aasbrenn, Martin, et al.
Publicado: (2018)

Changes in serum zonulin in individuals with morbid obesity after weight-loss interventions: a prospective cohort study
por: Aasbrenn, Martin, et al.
Publicado: (2020)

Diet in subjects with irritable bowel syndrome: A cross-sectional study in the general population
por: Ligaarden, Solveig C, et al.
Publicado: (2012)

IgG and IgG4 antibodies in subjects with irritable bowel syndrome: a case control study in the general population
por: Ligaarden, Solveig C, et al.
Publicado: (2012)

Are Nonnutritive Sweeteners Obesogenic? Associations between Diet, Faecal Microbiota, and Short-Chain Fatty Acids in Morbidly Obese Subjects
por: Farup, Per G., et al.
Publicado: (2019)

A candidate probiotic with unfavourable effects in subjects with irritable bowel syndrome: a randomised controlled trial
por: Ligaarden, Solveig C, et al.
Publicado: (2010)

Intake of non-nutritive sweeteners is associated with an unhealthy lifestyle: a cross-sectional study in subjects with morbid obesity
por: Winther, Robert, et al.
Publicado: (2017)

Changes in C-reactive protein, neopterin and lactoferrin differ after conservative and surgical weight loss in individuals with morbid obesity
por: Aasbrenn, Martin, et al.
Publicado: (2019)

Predicting satisfaction with outcome and follow‐up care 5 years after bariatric surgery: A prospective evaluation
por: Lundin Kvalem, Ingela, et al.
Publicado: (2022)

Abdominal pain and symptoms before and after Roux‐en‐Y gastric bypass
por: Chahal‐Kummen, M., et al.
Publicado: (2019)

Irritable Bowel Syndrome
por: Farup, Per G., et al.
Publicado: (2012)

Functional Bowel Disorders Are Associated with a Central Immune Activation
por: Farup, Per G., et al.
Publicado: (2017)

Cognitive Functions and Depression in Patients with Irritable Bowel Syndrome
por: Farup, Per G., et al.
Publicado: (2015)

Predictors of health-related quality of life in patients with irritable bowel syndrome. A cross-sectional study in Norway
por: Michalsen, Vilde Lehne, et al.
Publicado: (2015)

Drugs and Constipation in Elderly in Nursing Homes: What Is the Relation?
por: Fosnes, Gunvor S., et al.
Publicado: (2012)

Effectiveness of laxatives in elderly - a cross sectional study in nursing homes
por: Fosnes, Gunvor S, et al.
Publicado: (2011)

Constipation and diarrhoea - common adverse drug reactions? A cross sectional study in the general population
por: Fosnes, Gunvor S, et al.
Publicado: (2011)

Relationships Between Vitamin D Status and PTH over 5 Years After Roux-en-Y Gastric Bypass: a Longitudinal Cohort Study
por: Hewitt, Stephen, et al.
Publicado: (2020)

Faecal short-chain fatty acids - a diagnostic biomarker for irritable bowel syndrome?
por: Farup, Per G., et al.
Publicado: (2016)

Neuropsychological function in individuals with morbid obesity: a cross-sectional study
por: Sargénius, Hanna L., et al.
Publicado: (2017)

Are the Results of a Combined Behavioural and Surgical Treatment of Morbid Obesity Satisfactory and Predictable?
por: Farup, Per G
Publicado: (2020)

Separating “good” from “bad” faecal dysbiosis – evidence from two cross-sectional studies
por: Farup, Per G., et al.
Publicado: (2018)

APOE – a genetic marker of comorbidity in subjects with morbid obesity
por: Farup, Per G., et al.
Publicado: (2020)

Effects of a fall prevention program in elderly: a pragmatic observational study in two orthopedic departments
por: Røyset, Bodil, et al.
Publicado: (2019)

How does comorbidity affect cost of health care in patients with irritable bowel syndrome? A cohort study in general practice
por: Johansson, Per A, et al.
Publicado: (2010)

Probiotics, Symptoms, and Gut Microbiota: What Are the Relations? A Randomized Controlled Trial in Subjects with Irritable Bowel Syndrome
por: Farup, Per G., et al.
Publicado: (2012)

Anti-Saccharomyces cerevisiae antibodies (ASCA) are associated with body fat mass and systemic inflammation, but not with dietary yeast consumption: a cross-sectional study
por: Kvehaugen, Anne Stine, et al.
Publicado: (2017)

A comparison of behavioral and psychological characteristics of patients opting for surgical and conservative treatment for morbid obesity
por: Kvalem, Ingela Lundin, et al.
Publicado: (2016)

Faecal Microbial Markers and Psychobiological Disorders in Subjects with Morbid Obesity. A Cross-Sectional Study
por: Farup, Per G, et al.
Publicado: (2018)

Changes in Faecal Short-Chain Fatty Acids after Weight-Loss Interventions in Subjects with Morbid Obesity
por: Farup, Per G, et al.
Publicado: (2020)

Standard versus distal Roux-en-Y gastric bypass in patients with BMI 50–60 kg/m(2): 5-year outcomes of a double-blind, randomized clinical trial
por: Salte, Odd Bjørn Kjeldaas, et al.
Publicado: (2021)

Are Faecal Microbiota Analyses on Species-Level Suitable Clinical Biomarkers? A Pilot Study in Subjects with Morbid Obesity
por: Farup, Per G., et al.
Publicado: (2021)

Irritable bowel syndrome: Is it “irritable brain” or “irritable bowel”?
por: Padhy, Susanta Kumar, et al.
Publicado: (2015)

Visual, Verbal and Everyday Memory 2 Years After Bariatric Surgery: Poorer Memory Performance at 1-Year Follow-Up
por: Walø-Syversen, Gro, et al.
Publicado: (2021)

APOE Polymorphism and Endocrine Functions in Subjects with Morbid Obesity Undergoing Bariatric Surgery
por: Farup, Per G., et al.
Publicado: (2022)

Octogenarian patients with colon cancer – postoperative morbidity and mortality are the major challenges
por: Høydahl, Øystein, et al.
Publicado: (2022)

Circulating Lipoproteins in Subjects with Morbid Obesity Undergoing Bariatric Surgery with Gastric Bypass or Sleeve Gastrectomy
por: Aaseth, Jan O., et al.
Publicado: (2022)

The Current Prevalence of Irritable Bowel Syndrome in Asia
por: Chang, Full-Young, et al.
Publicado: (2010)

Prevalence of Irritable Bowel Syndrome in Northern India
por: Chua, Andrew Seng Boon
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_19290usin13n2s8f51hjjcsurk